Skip to content
Screener

Shift4 Payments FOUR Contingent consideration fair value adjustment

Contingent consideration fair value adjustment at other companies

Insmed logo
InsmedINSM
-$46.96M-357%
Blackrock logo
BlackrockBLK
$180M+2,100%
Lifetime Brands logo
Lifetime BrandsLCUT
$0—
Lifetime Brands logo
Lifetime BrandsLCUT
$0—
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$622K—
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$0—

Segments

By segment

See full
Reportable Segment$0-100%

Other financials

Income statement

See full
Revenue$1.3B+34.1%
Gross profit$446.0M+52.7%
Operating income$95.0M+14.5%
Net income$22.0M-35.3%
EPS (diluted)$0.08-75.0%

Balance sheet

See full
Cash & equivalents--100%
Total debt$4.6B+21.2%
Total equity$1.6B+1.6%
Total assets$8.7B+24.4%

Cash flow

See full
Operating cash flow$63.0M-55.6%
CapEx$6.0M+500%
Free cash flow$57.0M-59.6%

Valuation

See full
Market cap$3.44B-39.0%
P/E32.7×+7.2×
P/S0.7×-0.8×

Profitability

See full
Gross margin35.9%+5.4pp
Operating margin8.1%+0.5pp
Net margin2.2%-3.9pp
FCF margin12%-2.0pp

Returns & leverage

See full
Return on equity6.6%-12.7pp
Debt / equity2.8×+0.5×
Current ratio1.2×-1.3×